疏肝解郁活血通络法治疗冠心病的临床研究被引量：1

Clinical study on Shugan Jieyu Huoxue Tongluo method in the treatment of coronary heart disease

下载PDF

导出

摘要目的:探讨疏肝解郁活血通络法治疗冠心病的临床效果。方法:收治冠心病患者71例,分为治疗组与对照组,治疗组采用疏肝解郁活血通络法治疗,对照组采用西药治疗。结果:治疗组的疗效明显优于对照组(P<0.05)。结论:疏肝解郁活血通络法治疗冠心病的临床效果显著。 Objective:To explore the clinical effect of Shugan Jieyu Huoxue Tongluo method in the treatment of coronary heartdisease.Methods:71patients with coronary heart disease were selected.They were divided into the treatment group and the controlgroup.The treatment group was treated with Shugan Jieyu Huoxue Tongluo method.The control group was treated with westernmedicine treatment.Results:The curative effect of the treatment group was significantly better than that of the control group(P<0.05).Conclusion:The clinical effect of Shugan Jieyu Huoxue Tongluo method in the treatment of coronary heart disease wassignificant.

作者刘宏平刘忠斌 Liu Hongping;Liu Zhongbin(The Traditional Chinese Medicine Hospital of Liaoyuan City 136200)

机构地区辽源市中医院

出处《中国社区医师》 2017年第16期95-95,97,共2页 Chinese Community Doctors

关键词疏肝解郁活血通络冠心病 Shugan Jieyu Huoxue Tongluo Coronary heart disease

分类号 R259 [医药卫生—中西医结合]

引文网络
相关文献

参考文献2

1刘梅颜,张丽军,刘梦超.心肌梗死与抑郁大鼠5-羟色胺系统的前期干预研究[J].中华内科杂志,2016,55(9):700-704. 被引量：5
2刘玥,陈可冀.抑郁、焦虑状态与血栓形成：研究现状与思考[J].中华内科杂志,2016,55(9):670-672. 被引量：8

二级参考文献24

1Huffman JC, Celano CM, Beach SR, et al. Depression and cardiac disease: epidemiolngy, mechanisms, and diagnosis[ J ]. Cantiovar Psychiatry Neurol, 2013,2013: 695925. DOI: 10. 1155/2013/695925.
2Celano CM, Millstein RA, Bedoya CA, et al. Assaiation between anxiety mid mortMity in patients with conmary artery disease: A meta-analysis[J]. Am Heart J, 2015,170(6) :1105-1115. DOI: 10. 1016/j. ahj. 2015.09. 013.
3Lichtman JH, Froelicher ES, Blumenthal JA, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association [ J ]. Circulation, 2014, 129 ( 12 ) : 1350-1369. DOI: 10. 1161/CIR. 0000000000000019.
4Lim GB. Risk factors: depression recognized as a risk factor in ACS[J]. Nat Rev Cardiol, 2014,11 (4) :185. DOI: 10. 1038/ nrcardio. 2014.27.
5Bondy B. Common genetic factors for depression and cardiovascular disease[ J]. Dialogues Clin Neurosci, 2007,9( 1 ) : 19-28.
6Amadio P, Colombo GI, Tarantino E, et al. BDNF Va166Met polymorphism: a potential bridge between depression and thrombosis[J/OL]. Eur Heart J, 2015. [2016-03-05]. http:// eurheartj, oxford journals, org/content/early/2015/12/24/ eurheartj, ehv655, long. [ publishedonline ahead of print December 24.20151. DOI: 10. 1093/eurheartj/ehv655.
7Egan MF, Kojima M, Callicott JH, et al. The BDNF va166met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function [ J]. Cell, 2003,112 (2) :257-269.
8Liu YQ, Su GB, Duan CH, et al. Brain-derived neurotrophic factor gene polymorphisms are associated with coronary artery disease-related depression and antidepressant response [ J ]. Mol Med Rep,2014,10(6) :3247-3253. DOI: 10. 3892/mmr. 2014. 2638.
9Stein S, Winnik S, Matter CM. Brain-derived neurotrophic factor Va166Met polymorphism in depression and thrombosis: SIRT1 as a possible mediator [ J/OL]. Eur Heart J, 2015. [ 2016-03-05]. http://eurheartj, oxfordjournals, org/content/early/2015/12/28/ eurheartj, ehv692, long. [ publishedonline ahead of print December 24,2015 ]. DOI: 10. 1093/eurheartj/ehv692.
10Du J, Zhang D, Yin Y, et al. The Personality and Psychological Stress Predict Major Adverse Cardiovascular Events in Patients With Coronary Heart Disease After Pereutaneous Coronary Intervention for Five Years[ J]. Medicine ( Baltimore), 2016,95 (15) :e3364. DOI: 10. 1097/MD. 0000000000003364.